CHF 4.1
(-6.82%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 557 Thousand CHF | 145.37% |
2022 | 227 Thousand CHF | -41.94% |
2021 | 391 Thousand CHF | 0.0% |
2020 | - CHF | 0.0% |
2019 | - CHF | 100.0% |
2018 | -16.99 Thousand CHF | 29.17% |
2017 | -24 Thousand CHF | -2400100.0% |
2016 | 1.00 CHF | -99.99% |
2015 | 18.48 Thousand CHF | -96.89% |
2014 | 594 Thousand CHF | -77.84% |
2013 | 2.68 Million CHF | 0.0% |
2012 | - CHF | 0.0% |
2011 | - CHF | 0.0% |
2010 | - CHF | 0.0% |
2009 | - CHF | 0.0% |
2008 | - CHF | 0.0% |
2007 | - CHF | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | 374 Thousand CHF | 0.0% |
2023 Q4 | 557 Thousand CHF | 0.0% |
2023 FY | 557 Thousand CHF | 145.37% |
2023 Q2 | 450 Thousand CHF | 0.0% |
2022 FY | 227 Thousand CHF | -41.94% |
2022 Q4 | 227 Thousand CHF | 0.0% |
2022 Q2 | 243 Thousand CHF | 0.0% |
2021 FY | 391 Thousand CHF | 0.0% |
2021 Q2 | 223 Thousand CHF | 0.0% |
2021 Q4 | 391 Thousand CHF | 0.0% |
2020 FY | - CHF | 0.0% |
2020 Q4 | - CHF | 0.0% |
2020 Q2 | - CHF | 0.0% |
2019 Q2 | - CHF | 0.0% |
2019 FY | - CHF | 100.0% |
2019 Q4 | - CHF | 0.0% |
2018 Q4 | - CHF | 0.0% |
2018 Q2 | - CHF | 0.0% |
2018 FY | -16.99 Thousand CHF | 29.17% |
2017 FY | -24 Thousand CHF | -2400100.0% |
2017 Q4 | - CHF | 0.0% |
2017 Q2 | - CHF | 0.0% |
2016 Q4 | 1.00 CHF | 0.0% |
2016 Q2 | - CHF | 0.0% |
2016 FY | 1.00 CHF | -99.99% |
2015 Q4 | - CHF | 0.0% |
2015 Q2 | 860.21 Thousand CHF | 0.0% |
2015 FY | 18.48 Thousand CHF | -96.89% |
2014 Q2 | 1.9 Million CHF | 0.0% |
2014 FY | 594 Thousand CHF | -77.84% |
2014 Q4 | 594 Thousand CHF | 0.0% |
2013 FY | 2.68 Million CHF | 0.0% |
2013 Q4 | 2.68 Million CHF | 0.0% |
2013 Q2 | - CHF | 0.0% |
2012 Q4 | - CHF | 0.0% |
2012 FY | - CHF | 0.0% |
2012 Q2 | - CHF | 0.0% |
2011 Q2 | - CHF | 0.0% |
2011 Q4 | - CHF | 0.0% |
2011 FY | - CHF | 0.0% |
2010 Q2 | - CHF | 0.0% |
2010 FY | - CHF | 0.0% |
2010 Q4 | - CHF | 0.0% |
2009 Q4 | - CHF | 0.0% |
2009 FY | - CHF | 0.0% |
2009 Q2 | - CHF | 0.0% |
2008 FY | - CHF | 0.0% |
2008 Q4 | - CHF | 0.0% |
2007 FY | - CHF | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Addex Therapeutics Ltd | - CHF | -Infinity% |
BB Biotech AG | -2.63 Billion CHF | 100.021% |
Basilea Pharmaceutica AG | 26.41 Million CHF | 97.891% |
Evolva Holding SA | - CHF | -Infinity% |
Idorsia Ltd | 59.14 Million CHF | 99.058% |
Kuros Biosciences AG | 4.85 Million CHF | 88.53% |
Molecular Partners AG | - CHF | -Infinity% |
Santhera Pharmaceuticals Holding AG | 1.81 Million CHF | 69.244% |